Literature DB >> 16773704

Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis.

Marco Marzioni1, Giammarco Fava, Antonio Benedetti.   

Abstract

Cholangiocytes, the epithelial cells lining the biliary ducts, are the target cells in several liver diseases. Cholangiopathies and cholangiocarcinoma generate interest in many scientists since the genesis. The developing mechanisms, and the therapeutic tools of these diseases are still undefined. Several studies demonstrate that many hormones, neuropeptides and neurotransmitters regulate malignant and non-malignant cholangiocyte pathophysiology in the course of chronic biliary diseases. The aim of this review is to present the findings of several studies published in the recent years that contributed to clarifying the role of nervous and neuroendocrine regulation of the pathophysiologic events associated with cholestasis and cholangiocarcinoma development. This manuscript is organized into two parts. The first part offers an overview of the innervation of the liver and the origin of neuroendocrine hormones, neurotransmitters and neuropeptides affecting cholangiocyte function and metabolism. The first section also reviews the effects played by several neuroendocrine hormones and nervous system on cholangiocyte growth, survival and functional activity in the course of cholestasis. In the second section, we summarize the results of some studies describing the role of nervous system and neuroendocrine hormones in the regulation of malignant cholangiocyte growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773704      PMCID: PMC4087563          DOI: 10.3748/wjg.v12.i22.3471

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  105 in total

1.  Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.

Authors:  Marco Marzioni; Heather Francis; Antonio Benedetti; Yoshiyuki Ueno; Giammarco Fava; Juliet Venter; Ramona Reichenbach; Maria Grazia Mancino; Ryun Summers; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt.

Authors:  Shannon Glaser; Domenico Alvaro; Heather Francis; Yoshiyuki Ueno; Luca Marucci; Antonio Benedetti; Sharon De Morrow; Marco Marzioni; Maria Grazia Mancino; Jo Lynne Phinizy; Ramona Reichenbach; Giammarco Fava; Ryun Summers; Julie Venter; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-08       Impact factor: 4.052

3.  [Novel therapeutics strategies in benign hypertrophy of prostate management].

Authors:  Th Roumeguère
Journal:  Rev Med Brux       Date:  2005-09

4.  gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway.

Authors:  Giammarco Fava; Luca Marucci; Shannon Glaser; Heather Francis; Sharon De Morrow; Antonio Benedetti; Domenico Alvaro; Julie Venter; Cynthia Meininger; Tushar Patel; Silvia Taffetani; Marco Marzioni; Ryun Summers; Ramona Reichenbach; Gianfranco Alpini
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

5.  Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas.

Authors:  Manory A Fernando; Anthony P Heaney
Journal:  Mol Endocrinol       Date:  2005-07-14

6.  Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase a isoform content.

Authors:  R J Bold; S Alpard; J Ishizuka; C M Townsend; J C Thompson
Journal:  Regul Pept       Date:  1994-08-31

7.  Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition.

Authors:  C K Tan; P V Podila; J E Taylor; D M Nagorney; G A Wiseman; G J Gores; N F LaRusso
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

8.  Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes.

Authors:  P S Tietz; G Alpini; L D Pham; N F Larusso
Journal:  Am J Physiol       Date:  1995-07

9.  Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver.

Authors:  G Alpini; S Roberts; S M Kuntz; Y Ueno; S Gubba; P V Podila; G LeSage; N F LaRusso
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

10.  Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangio-cellular and undifferentiated carcinomas after transformation.

Authors:  P Steinberg; R Steinbrecher; S Radaeva; P Schirmacher; H P Dienes; F Oesch; P Bannasch
Journal:  Lab Invest       Date:  1994-11       Impact factor: 5.662

View more
  13 in total

Review 1.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

2.  Involvement of cholangiocyte proliferation in biliary fibrosis.

Authors:  Sally Priester; Candace Wise; Shannon S Glaser
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

Review 3.  Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease.

Authors:  Laurent Ehrlich; Marinda Scrushy; Fanyin Meng; Terry C Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  Clin Res Hepatol Gastroenterol       Date:  2018-04-17       Impact factor: 2.947

Review 4.  Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis.

Authors:  Shannon S Glaser; Paolo Onori; Candace Wise; Fuguan Yang; Marco Marzioni; Domenico Alvaro; Antonio Franchitto; Romina Mancinelli; Gianfranco Alpini; Md Kamruzzaman Munshi; Eugenio Gaudio
Journal:  Dig Liver Dis       Date:  2010-02-13       Impact factor: 4.088

Review 5.  Adenylyl cyclases in the digestive system.

Authors:  Maria Eugenia Sabbatini; Fred Gorelick; Shannon Glaser
Journal:  Cell Signal       Date:  2014-02-09       Impact factor: 4.315

6.  Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.

Authors:  Giammarco Fava; Sharon Demorrow; Eugenio Gaudio; Antonio Franchitto; Paolo Onori; Guido Carpino; Shannon Glaser; Heather Francis; Monique Coufal; Luca Marucci; Domenico Alvaro; Marco Marzioni; Trenton Horst; Romina Mancinelli; Antonio Benedetti; Gianfranco Alpini
Journal:  Liver Int       Date:  2009-03-09       Impact factor: 5.828

7.  Leptin enhances cholangiocarcinoma cell growth.

Authors:  Giammarco Fava; Gianfranco Alpini; Chiara Rychlicki; Stefania Saccomanno; Sharon DeMorrow; Luciano Trozzi; Cinzia Candelaresi; Julie Venter; Antonio Di Sario; Marco Marzioni; Italo Bearzi; Shannon Glaser; Domenico Alvaro; Luca Marucci; Heather Francis; Gianluca Svegliati-Baroni; Antonio Benedetti
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 8.  Mechanisms of biliary carcinogenesis and growth.

Authors:  Candace Wise; Metaneeya Pilanthananond; Benjamin-F Perry; Gianfranco Alpini; Michael McNeal; Shannon-S Glaser
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

Review 9.  Genetic and molecular abnormalities in cholangiocarcinogenesis.

Authors:  Victor J Hassid; Frank A Orlando; Ziad T Awad; Dongfeng Tan; Thaer Khoury; Bestoun H Ahmed; Sadir J Alrawi
Journal:  Anticancer Res       Date:  2009-04       Impact factor: 2.480

10.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.